CClinicalTrials.gg
CompletedNCT01663844Updated Jul 18, 2022

New Clinical Applications for Internet-based Cognitive Behavior Therapy for Insomnia and Depression

An interventional study of Therapist guided Internet-CBT for insomnia w. extra support and Therapist guided Internet-CBT for insomnia in Insomnia, Major Depression and Minor Depression, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-18.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
440
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study includes two sub-trials. Both are included in this singe registration since they have parallel inclusion of participants and have been approved by the Swedish ethics board together in one application.

Trial 1 includes patients with both insomnia and major or minor depression. Participants are randomized to either a combined therapist guided Internet-CBT for insomnia and depression, or to Internet-CBT for depression with an addition of a placebo intervention for insomnia. The primary purpose is to evaluate changes in insomnia and depression severity for the combination treatment compared to the depression treatment, after treatment and at 6 and 36 months follow up. A secondary purpose is to evaluate cognitive functioning before and after treatment, as well as cost effectiveness. Recruitment is done in the Stockholm County through mass media and the Internet psychiatry clinic's regular patient recruitment.

Trial 2 includes patients with insomnia who do not meet criteria for major or minor depression. All participants start therapist guided Internet-CBT for insomnia. After 4 weeks patients that are judged to be at risk of treatment failure are randomized to either continued treatment or treatment with added support intended to enhance outcome. The primary purpose is to evaluate change in insomnia severity for participants who get added support, compared to continued treatment with regular support level. A secondary purpose is to evaluate cognitive functioning before and after treatment, as well as cost effectiveness. Recruitment is done in the Stockholm County through mass media and the Internet psychiatry clinic's regular patient recruitment.

NOTE:

The first participants in trial 1 will be regarded as pilots, due to problems with the experimental treatment: technical issues as well as problems with the design of treatment modules. These problems were corrected when discovered. 12 participants in the experimental arm were affected by these errors. The pilot participants will not be included in the main analyses of data. This was decided upon on 31st of October 2014.

02

Conditions studied

  • Insomnia
  • Major Depression
  • Minor Depression

Keywords

  • Cognitive behavior therapy
  • Internet treatment
  • Self-help treatment
  • Insomnia
  • Depression
  • ICBT
  • CBT-i
  • CBT-d
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's planned enrollment of 440 is above the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical level of Insomnia (more than 10 on ISI)
  • Meets criteria for Insomnia according to DSM-IV-TR
  • Enough language skills
  • Only Trial 1: Meets criteria for Major or Minor Depressive Disorder according to DSM-IV-TR (for minor depression a MADRS-S-level of >19 is required).

Exclusion criteria

Exclusion Criteria:

  • Sleep disorders requiring other treatment
  • Alcohol/drugs abuse
  • Started to use or changed the dose of antidepressant drug during the last 2 months
  • Somatic or psychiatric conditions requiring acute care
  • Working night shifts
  • Only Trial 2: Meets criteria for Major or Minor Depressive Disorder according to DSM-IV-TR (for minor depression a MADRS-S-level of >19 is required for exclusion).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
440 participants (estimated)

Study arms

  • Experimental
    (Study 1) ICBT for insomnia and depression

    Behavioral: Therapist guided Internet-CBT for insomnia and depression

  • Active comparator
    (Study 1) ICBT for depr. plus placebo insomnia intervention

    Behavioral: Therapist Guided Internet-CBT for depression plus insomnia placebo

  • Experimental
    (Study 2) ICBT for insomnia with added support

    Behavioral: Therapist guided Internet-CBT for insomnia w. extra support

  • Active comparator
    (Study 2) ICBT for insomnia with regular level of support

    Behavioral: Therapist guided Internet-CBT for insomnia

Interventions

  • BehavioralTherapist guided Internet-CBT for insomnia w. extra support

    (Study 2) A 9 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for insomnia plus extra therapist support.

  • BehavioralTherapist guided Internet-CBT for insomnia

    (Study 2) A 9 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for insomnia. Regular therapist support.

  • BehavioralTherapist guided Internet-CBT for insomnia and depression

    (Study 1) A 12 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for insomnia and depression.

  • BehavioralTherapist Guided Internet-CBT for depression plus insomnia placebo

    (Study 1) A 12 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression. A placebo intervention for insomnia is added.

06

What researchers measure

Primary outcomes

  1. Change (from baseline) in Insomnia Severity Index (ISI)

    7-item, self-rated questionnaire measuring change in insomnia severity. Bastien, C. H., Vallières, A., \& Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.

    Time frame: 0, 6 and 36 months after treatment

  2. Change (from baseline) in Montgomery Asberg Depression Rating Scale, MADRS-S

    Defined as secondary outcome measure in Trial 2. The use of two primary outcomes in trial 1 is motivated since participants have both diagnoses and the purpose is to look at effects on both insomnia and depression. The MADRS-S is a 9-item self-rated measure of change in depression severity. It also screens for suicidality. Mattila-Evenden, M., Svanborg, P., Gustavsson, P., \& Åsberg, M. (1996). Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of CPRS. Acta Psychiatr Scand, 94, 386-396.

    Time frame: 0, 6 and 36 months after treatment

Secondary outcomes

  1. Change (from baseline) in Sleep Diary

    One week of self-ratings on a number of sleep parameters, resulting in measures of sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings, subjective sleep quality and daytime functioning.

    Time frame: Directly after treatment

  2. Changes (from baseline) in Actigraph data

    An actigraph is placed on the participant's arm for one week. They measure participants' activity in the form of movements. It will be used for acquiring sleep data and calculate sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings and daytime activity.

    Time frame: Directly post treatment

  3. Change (from baseline) in Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)

    Health economic questionnaire evaluation cost for health care, absence of work capacity and related costs. Hakkaart-Van Roijen, L.,Van Straten, A., \& Donker, M. (2002). Manual: Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness. Rotterdam: Erasmus University

    Time frame: 0, 6 and 36 months after treatment

  4. Change (from baseline) in Cognitive functioning

    Computer based testing of executive functions, concentration, speed and memory.

    Time frame: Directly at post-treatment

  5. Change (from baseline) in EuroQuol. EQ-5D

    General quality of life measure to complement the TIC-P in health economic analysis. Hinz, A., Klaiberg, A., Brahler, E., \& Konig, H.H. (2006). The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population. Psychother.Psychosom.Med.Psychol., 56, 42-48.

    Time frame: 0, 6 and 36 months after treatment

  6. Change (from baseline) in Sheehan Disability Scale

    Measures daily life functioning. Sheehan, D. V. (1983). The Anxiety disease. Scribner: New York

    Time frame: 0, 6 and 36 months after treatment

  7. Change (from baseline) in Clinical Outcome in Routine Evaluation - 10, CORE-OM

    Measures psychological health in general. Evans, C., Connell, J., Barkham, M., Margison, F., McGrath, G., Mellor-Clark, J. \& Audin, K. (2002). Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM. The British journal of psychiatry : the journal of mental science 180, 51-60.

    Time frame: 0, 6 and 36 months after treatment

07

Study locations

1 site
  • Internetpsykiatrienheten (Internet Psychiatry Clinic) Psykiatri Sydväst, SLSO
    Stockholm, S-14186, Sweden
08

References and documents

Publications

  • Kraepelien M, Blom K, Forsell E, Hentati Isacsson N, Bjurner P, Morin CM, Jernelov S, Kaldo V. A very brief self-report scale for measuring insomnia severity using two items from the Insomnia Severity Index - development and validation in a clinical population. Sleep Med. 2021 May;81:365-374. doi: 10.1016/j.sleep.2021.03.003. Epub 2021 Mar 16. PubMed 33813233 ↗
  • Forsell E, Jernelov S, Blom K, Kraepelien M, Svanborg C, Andersson G, Lindefors N, Kaldo V. Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients. Am J Psychiatry. 2019 Apr 1;176(4):315-323. doi: 10.1176/appi.ajp.2018.18060699. Epub 2019 Jan 30. PubMed 30696270 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01663844
Lead sponsor
Karolinska Institutet
Collaborators
Region Stockholm
Responsible party
Viktor Kaldo (Principal Investigator, Karolinska Institutet) — Principal investigator
First posted
Aug 13, 2012
Start date
Jan 2013
Primary completion
Dec 2018
Completion
May 2022
Last update
Jul 18, 2022

Study contacts

Viktor Kaldo, PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion